US Medicare To Codify Inflation Rebates, Adds Reconciliation Process

The US Medicare agency is creating a formal reconciliation process for new inflation rebates in Part B and Part D of the program.

rebate
Going forward, Part B rebates will be invoiced quarterly, while Part D rebates will be invoiced annually. • Source: Shutterstock

The US Centers for Medicare and Medicaid Services is planning to create a formal reconciliation process for the Medicare Part B and Part D inflation rebate programs, the agency said in a proposed regulatory codification of the new rebates created via the 2022 Inflation Reduction Act.

Key Takeaways
  • A formal reconciliation process will be created for Medicare Parts B and D inflation rebates.

CMS is proposing the inflation rebate policies in the annual update rule to the Part B Physician Fee Schedule. The...

More from Medicare

How Could MFN Pricing Impact Commercial Market?

 
• By 

Industry experts forecast the impact of President Trump's Most-Favored Nation drug pricing policy on the commercial insurance industry.

Medicare’s Combo Products Negotiation Plan Conflicts With US FDA Standards, Firms Argue

 
• By 

The plan could curtail a period of pricing flexibility for newer subcutaneous versions of important oncology drugs.

Oz Says Big PBMs Have ‘Window’ to Quit Rebate System on Their Own

 
• By 

CMS Administrator Mehmet Oz said PBMs may deserve "one last chance" to fix the rebate system before federal regulations and legislation are enacted.

Price Inflation Rebates: Biden Policies Add Teeth To Trump’s Pharma Tariff Threat

 
• By 

Companies with significant exposure to Medicare and Medicaid have fewer options for passing along higher costs to consumers because of price controls in the programs.

More from Government Payers

Oz Says Big PBMs Have ‘Window’ to Quit Rebate System on Their Own

 
• By 

CMS Administrator Mehmet Oz said PBMs may deserve "one last chance" to fix the rebate system before federal regulations and legislation are enacted.

Canada Unveils Draft List of Essential Drugs For Universal Pharmacare

 

The list of essential prescription drugs and related products will shape Canada’s first national formulary for the country’s universal pharmacare program.

Repurposed Drugs: EU Pharma Reform Offers Boost, But Payers ‘Must Recognize Health Gains’

 

Incentives for repurposed drugs proposed as part of the EU pharma reform package are a “great step forward,” but more recognition is needed from payers and regulators to leverage the benefits of these medicines, experts say.